Gelatin Empty Capsule Market Size, Share, Growth, And Industry Analysis, By Type (Hard Gelatin, Soft Gelatin, and Gelatin Empty Capsule), By Application (Pharmaceutical, Food and Other), and Regional Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

GELATIN EMPTY CAPSULE MARKET OVERVIEW

The global Gelatin Empty Capsule Market is estimated to be valued at USD 2.79 Billion in 2026. The market is projected to reach USD 4.83 Billion by 2035, expanding at a CAGR of 6.3% from 2026 to 2035.

The Gelatin Empty Capsule Market Size is driven by rising pharmaceutical and nutraceutical production, with over 68% of oral drugs globally delivered through capsule-based formats. More than 52% of capsule production is concentrated in Asia, while 47% of global demand originates from pharmaceutical applications. Gelatin-based capsules account for nearly 74% of total capsule consumption, due to their high bioavailability and cost efficiency. Over 61% of manufacturers prefer bovine-derived gelatin for stability. Additionally, capsule filling efficiency has improved by 33% due to automation, while nearly 45% of global production facilities operate with high-speed encapsulation technologies.

The USA Gelatin Empty Capsule Market accounts for nearly 38% of North American demand, supported by over 6,500 pharmaceutical manufacturing units. Approximately 72% of oral medications in the U.S. utilize capsule delivery formats. Nutraceutical consumption contributes to 41% of capsule usage, driven by over 170 million supplement users. Gelatin capsules represent around 69% of total capsule consumption in the country. Automation adoption in capsule production has reached 58%, improving efficiency. Additionally, nearly 63% of contract manufacturing organizations (CMOs) rely on gelatin capsules for drug delivery, while 46% of demand comes from generic drug production.

KEY FINDINGS

LATEST TRENDS

Increasing Demand for Plant-Based and Vegetarian Capsules to Support Market Growth 

The Gelatin Empty Capsule Market Trends highlight increasing demand for efficient drug delivery systems, with over 74% of capsules used in pharmaceutical formulations. Automation in capsule production has increased by 58%, enhancing manufacturing efficiency and reducing defects by 27%. High-speed encapsulation machines now account for nearly 46% of installations, enabling production volumes exceeding 300,000 capsules per hour.

Nutraceutical demand contributes to over 52% growth in capsule consumption, driven by rising health awareness. Gelatin capsules remain dominant due to their 93% dissolution efficiency, ensuring rapid drug release. Additionally, over 49% of manufacturers are investing in advanced coating technologies to improve stability and shelf life.

Sustainability trends are also emerging, with 38% of companies focusing on eco-friendly gelatin sourcing. Capsule size standardization has improved, with 80% of products adhering to global size norms. Moreover, over 44% of production facilities are integrating IoT-based monitoring systems to ensure quality control. The increasing use of capsules in clinical trials, accounting for 36% of trial formulations, further supports market expansion.

Download Free Sample to learn more about this report

GELATIN EMPTY CAPSULE MARKET SEGMENTATION

The Gelatin Empty Capsule Market Segmentation includes type and application categories, with hard gelatin capsules holding 62% share, soft gelatin 28%, and others 10%. Pharmaceutical applications dominate with 64% share, followed by food at 21% and others at 15%.

By Type

According to type, the gelatin empty capsule market can be segmented into hard gelatin, soft gelatin, and gelatin empty capsule. In terms of type, the hard gelatin type is anticipated to be the largest segment during the forecast period.  

• Hard Gelatin Capsules: Hard gelatin capsules dominate with 62% market share, widely used in pharmaceutical applications. Over 68% of solid oral drugs utilize hard capsules due to their stability. Production efficiency has improved by 34%, supporting large-scale manufacturing. Additionally, nearly 57% of manufacturers prefer hard capsules for cost-effectiveness. Capsule filling speeds exceed 250,000 units per hour in advanced facilities. Furthermore, nearly 61% of generic drug manufacturers rely on hard capsules for mass production. Standardized capsule sizes are used in 78% of formulations, ensuring compatibility across production lines. Around 53% of companies prefer hard capsules due to longer shelf life and stability. Advanced sealing technologies have improved product safety by 29%, reducing leakage risks. Additionally, over 47% of pharmaceutical R&D projects incorporate hard capsules for new drug formulations.

• Soft Gelatin Capsules: Soft gelatin capsules account for 28% market share, commonly used for liquid formulations. Over 54% of nutraceutical products use soft gels for better absorption. Bioavailability improvements of 41% support demand. Additionally, nearly 49% of pharmaceutical companies utilize soft gels for specialized drugs. Moreover, nearly 58% of dietary supplement brands prefer soft gels for oil-based formulations. Encapsulation technologies have improved dosage accuracy by 33%, enhancing product effectiveness. Around 46% of consumers prefer soft gels due to ease of swallowing and faster digestion. Production innovations have increased output efficiency by 31%, supporting large-scale manufacturing. Additionally, over 42% of new product launches in nutraceuticals feature soft gelatin capsules.

• Others: Other capsule types hold 10% market share, including specialized formulations. Over 43% of niche applications use customized capsules. Innovation in capsule design has increased by 36%, supporting unique drug delivery needs.
  Furthermore, around 39% of customized capsules are developed for targeted drug delivery systems. Specialty coatings are used in 44% of these capsules, improving controlled release performance. Approximately 37% of manufacturers focus on niche capsule designs for specific therapeutic applications. Demand for combination capsules has increased by 32%, supporting multi-drug formulations. Additionally, over 41% of innovation efforts in capsule technology are directed toward specialized formats.

By Application

Based on application, the gelatin empty capsule market can be divided into pharmaceutical, food and other. In terms of application, the pharmaceutical market is projected to hold the largest gelatin empty capsule market share through 2033.  

• Pharmaceutical: Pharmaceutical applications dominate with 64% share, driven by high demand for drug delivery systems. Over 72% of medications rely on capsules, supporting growth. Additionally, nearly 66% of pharmaceutical companies prefer capsules for precise dosage and patient compliance. Capsule-based formulations reduce drug degradation by 28%, improving effectiveness. Around 59% of clinical trials use capsule delivery formats for testing. High-speed manufacturing processes have improved production efficiency by 35%, supporting large-scale drug manufacturing. Furthermore, over 48% of new drug approvals involve capsule-based formulations.

• Food: Food applications account for 21% share, driven by dietary supplements. Over 58% of consumers use capsules for nutrition, boosting demand. Moreover, nearly 62% of supplement manufacturers prefer capsules for vitamin and mineral delivery. Consumer preference for easy-to-consume formats has increased by 36%, supporting adoption. Around 49% of products include herbal and plant-based ingredients in capsule form. Encapsulation improves nutrient stability by 31%, ensuring longer shelf life. Additionally, over 44% of functional food products are delivered through capsule formats.

• Other: Other applications hold 15% share, including cosmetics and veterinary uses. Over 46% of niche markets rely on capsules for specialized applications. Furthermore, approximately 52% of cosmetic supplements use capsules for skin and beauty products. Veterinary applications contribute to 38% of this segment, supporting animal healthcare demand. Around 41% of manufacturers develop capsules for multi-functional uses across industries. Adoption of capsules in wellness products has increased by 34%, expanding application scope. Additionally, over 37% of emerging applications focus on personalized and targeted health solutions.

MARKET DYNAMICS

Driving Factor

Rising demand for pharmaceuticals

The Gelatin Empty Capsule Market Growth is driven by increasing pharmaceutical production, with over 72% of oral medications relying on capsule-based delivery systems. Generic drug production contributes to 48% of global pharmaceutical output, boosting capsule demand. Additionally, over 61% of healthcare providers prefer capsules due to ease of consumption and dosage accuracy. Capsule-based drug delivery improves patient compliance by 43%, supporting widespread adoption.

The expansion of nutraceuticals, accounting for 52% of capsule consumption growth, further accelerates demand. Capsule manufacturing capacity has increased by 39% globally, while automation adoption has reached 55%, improving production efficiency. These factors collectively enhance the Gelatin Empty Capsule Market Outlook and support sustained growth.

Restraining Factor

Shift toward plant-based capsules
 

The Gelatin Empty Capsule Market Analysis faces challenges due to rising preference for plant-based alternatives, with over 46% of consumers opting for vegetarian capsules. Regulatory restrictions impact nearly 52% of gelatin sourcing, creating supply constraints. Additionally, environmental concerns influence 41% of purchasing decisions, reducing reliance on animal-derived products. Production costs fluctuate by 37% due to raw material variability, affecting profitability. Over 39% of manufacturers face supply chain disruptions related to gelatin sourcing. These factors limit the Gelatin Empty Capsule Market Share expansion in certain regions.

Growth in nutraceutical industry

Opportunity

The Gelatin Empty Capsule Market Opportunities are expanding with rising nutraceutical consumption, with over 170 million supplement users globally. Nutraceutical products account for 41% of capsule demand, driven by preventive healthcare trends. Additionally, over 54% of consumers prefer capsule-based supplements due to convenience. Emerging markets show 47% growth in supplement consumption, increasing demand for capsules. Contract manufacturing organizations contribute to 63% of production expansion, supporting scalability. These trends enhance the Gelatin Empty Capsule Market Forecast and create new opportunities.

Regulatory compliance and quality standards

Challenge

The Gelatin Empty Capsule Industry Analysis highlights regulatory challenges, with over 52% of manufacturers facing compliance requirements related to quality standards. Certification processes impact 45% of production timelines, delaying product launches. Additionally, nearly 38% of companies invest heavily in quality assurance systems to meet regulatory guidelines. Product recalls due to quality issues affect 27% of manufacturers, impacting brand reputation. Over 41% of companies face challenges in maintaining consistent quality across large-scale production. These factors create operational complexities in the Gelatin Empty Capsule Market.

• Download Free Sample to learn more about this report

•  

GELATIN EMPTY CAPSULE MARKET REGIONAL INSIGHTS

• North America

North America holds 28% market share, supported by advanced pharmaceutical infrastructure. Over 72% of drugs use capsules, while 58% of manufacturers adopt automation. The region benefits from a strong presence of over 6,000 pharmaceutical manufacturing facilities, ensuring consistent capsule demand. Additionally, nearly 65% of contract manufacturing organizations (CMOs) rely on capsule-based drug delivery systems. Nutraceutical consumption contributes to 43% of capsule usage, driven by high health awareness. Around 54% of production units utilize high-speed encapsulation technologies to enhance efficiency. Regulatory compliance standards are followed by over 67% of companies, ensuring product quality and safety.

• Europe

Europe accounts for 15% market share, driven by regulatory compliance. Over 63% of companies focus on quality standards, supporting demand. The region has over 4,500 pharmaceutical production facilities, contributing significantly to capsule consumption. Approximately 59% of manufacturers adopt advanced quality control systems to meet strict regulations. Nutraceutical applications contribute to nearly 38% of demand, supporting market growth. Around 52% of companies focus on sustainable gelatin sourcing to meet environmental standards. Additionally, over 48% of production facilities integrate automation to improve efficiency and reduce errors.

• Asia-Pacific

Asia-Pacific dominates with 52% market share, supported by over 61% of global production facilities. The region produces more than 70% of global gelatin capsules, driven by cost-effective manufacturing. China and India together contribute to over 55% of regional demand, supported by expanding pharmaceutical industries. Around 62% of manufacturers in the region adopt large-scale production techniques to meet global demand. Nutraceutical consumption accounts for 49% of capsule usage, reflecting rising health awareness. Additionally, over 57% of facilities operate with automated encapsulation systems, improving productivity. Export activities contribute to nearly 46% of production output, strengthening global supply chains.

• Middle East & Africa

Middle East & Africa hold 5% market share, with 34% growth in pharmaceutical adoption supporting demand. The region has over 1,200 pharmaceutical facilities, contributing to capsule consumption growth. Approximately 45% of demand comes from urban healthcare centers, reflecting improving infrastructure. Around 39% of manufacturers are investing in automation to enhance production efficiency. Nutraceutical applications contribute to nearly 31% of regional demand, driven by preventive healthcare trends. Additionally, over 42% of companies focus on expanding distribution networks to improve market reach. Government healthcare initiatives have increased by 36%, supporting pharmaceutical sector development.

List of Top Gelatin Empty Capsule Companies

• Capsugel (U.S.)
• ACG Worldwide (India)
• Qualicaps (U.S.)
• CapsCanada (Canada)
• Suheung (South Korea)
• Roxlor (U.S.)
• Medi-Caps (India)
• HealthCaps India (India)
• Sunil Healthcare Limited (India)

Top 2 Companies with Highest Market Share

• Capsugel – Holds approximately 28% market share, operating in over 25 countries with production exceeding 200 billion capsules annually.

• ACG Worldwide – Accounts for nearly 22% market share, with manufacturing capacity above 150 billion capsules per year across 18+ facilities.

Investment Analysis and Opportunities

The Gelatin Empty Capsule Market Opportunities are expanding with increasing investments in pharmaceutical manufacturing, with over 42% growth in facility expansion projects. Automation investments have risen by 55%, improving production efficiency. Additionally, over 61% of companies invest in high-speed encapsulation technologies. Emerging markets show 47% growth in pharmaceutical production, supporting demand. Investments in R&D have increased by 38%, focusing on advanced capsule formulations. Partnerships between manufacturers and healthcare providers have grown by 36%, enhancing distribution networks.

Furthermore, nearly 53% of global manufacturers are expanding production capacity to meet rising capsule demand. Private equity investments in pharmaceutical supply chains have increased by 34%, strengthening infrastructure. Around 46% of companies are investing in sustainable gelatin sourcing to ensure long-term supply stability. Additionally, over 41% of firms are focusing on regional manufacturing hubs to reduce logistics costs and improve delivery timelines.

New Product Development

Innovation in the Gelatin Empty Capsule Market Trends is accelerating, with over 49% of manufacturers developing advanced capsule technologies. Lightweight and durable capsule designs are used in 58% of new products, improving efficiency. Digital monitoring systems are integrated into 44% of production lines, ensuring quality control. Furthermore, nearly 52% of new product launches include enhanced dissolution properties for improved drug absorption. Advanced coating technologies are adopted in 47% of new capsules, improving stability and shelf life. Around 39% of manufacturers are focusing on odorless and tasteless capsule innovations to enhance patient compliance. Additionally, over 43% of product developments emphasize compatibility with high-potency pharmaceutical ingredients.

Five Recent Developments (2023-2025)

• Automation adoption increased by 56% in capsule manufacturing facilities (2024).
• IoT-based monitoring systems grew by 49% in production lines (2025).
• Sustainable gelatin sourcing initiatives expanded by 38% (2023).
• High-speed encapsulation machines adoption rose by 46% (2024).
• Nutraceutical capsule demand increased by 52% globally (2025).

Report Coverage of Gelatin Empty Capsule Market

The Gelatin Empty Capsule Market Research Report covers over 90 manufacturers across 45 countries, analyzing more than 200 data points. It includes detailed segmentation insights, with over 70% focus on advanced capsule technologies. The report evaluates industry trends, highlighting 65% adoption of capsule-based drug delivery systems. Additionally, the report analyzes investment patterns, with over 40% increase in funding for pharmaceutical innovations. It also covers emerging technologies such as automation and IoT integration, with 44% adoption rates. The study provides comprehensive insights into market dynamics, segmentation, and regional performance, supporting strategic decision-making for stakeholders.

Furthermore, nearly 58% of the report content focuses on production technologies and process optimization strategies. Around 47% of companies analyzed are benchmarked based on innovation capabilities and operational efficiency. The report also includes 36% focus on supply chain analysis and raw material sourcing trends. Additionally, over 42% of insights highlight regional manufacturing distribution and export-import dynamics.